Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Overview of Plasmapheresis MarketThe Global Plasmapheresis Market is valued at USD 1.34 Billion in 2024 and is projected to ...

Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.

New research reveals that the pandemic may have aged our brains, even without a COVID infection—linking isolation, stress, ...

Following reports of Guillain-Barré Syndrome (GBS) cases, the Navi Mumbai Municipal Corporation (NMMC) has appealed to citizens not to panic and to seek immediate medical attention at municipal ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Mysuru: Following the state govt's move to form an expert committee to investigate a surge in sudden cardiac deaths, Mysuru-based neurologists have ur.

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

Multiple sclerosis affects everyone differently. Learn what experts currently know about possible multiple sclerosis causes and risk factors, such as the immune system.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

SEATTLE — It is one of the most horrific tragedies for a parent: the sudden, unexplained death of a seemingly healthy baby. Now, a leading researcher on Sudden Infant Death Syndrome (SIDS) says ...